+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Interventional Oncology Market Size, Share & Trends Analysis Report by Technique, Procedures, Application, End-use, and Region with Growth Forecasts, 2026-2033

  • PDF Icon

    Report

  • 210 Pages
  • December 2025
  • Region: Global
  • Grand View Research
  • ID: 5990575
REQUEST CUSTOMIZATION
Description Jump to:
The global interventional oncology market size was estimated at USD 2.90 billion in 2025 and is projected to reach USD 5.61 billion by 2033, growing at a CAGR of 8.59% from 2026 to 2033. This growth can be attributed to the increasing prevalence of cancer, increasing technological advancements in minimally invasive procedures, growing geriatric population, rising focus on early cancer detection, and increasing public and private investments in the field of interventional oncology.

There is a significant rise in the number of cancer cases globally, increasing the need for advanced solutions facilitating better cancer care according to WHO, in 2022, approximately 20 million new cancer cases and 9.7 million deaths occurred. By 2050, cases are projected to rise to over 35 million, marking a 77% increase in the global cancer burden.Interventional oncology, with its array of minimally invasive techniques such as radiofrequency ablation (RFA), transarterial chemoembolization (TACE), and cryoablation, offers significant advantages over traditional surgery, including reduced recovery times and lower complication rates. As the global cancer burden continues to rise, the adoption of these advanced interventional techniques is expected to accelerate, driven by their ability to improve patient outcomes and quality of life.

The rising global incidence of cancer is largely attributed to increasing tobacco use, unhealthy diets, alcohol consumption, air pollution, and physical inactivity. This surge in cancer cases poses a significant challenge for healthcare systems, spurring the development of advanced solutions that offer better results and outcomes. Interventional oncology, which provides a minimally invasive alternative to traditional cancer treatments such as surgery, radiation, and chemotherapy, has become increasingly popular. Its advantages in terms of reduced patient trauma and quicker recovery times are key factors driving market growth.

These staggering statistics highlight the urgent need for effective cancer treatments. Interventional oncology, with its array of minimally invasive techniques such as radiofrequency ablation (RFA), transarterial chemoembolization (TACE), and cryoablation, offers significant advantages over traditional surgery, including reduced recovery times and lower complication rates. As the global cancer burden continues to rise, the adoption of these advanced interventional techniques is expected to accelerate, driven by their ability to improve patient outcomes and quality of life.

Companies in the interventional oncology market are actively pursuing various strategies to develop advanced solutions aimed at improving patient treatment and care. For example, in April 2021, Terumo launched its global therapeutic interventional oncology team to achieve excellence in interventional oncology solutions, with the goal of enhancing patient quality of life and survival rates. Such initiatives are expected to spur the development of innovative solutions, increasing the adoption of interventional oncology and driving market growth.

Moreover, increased efforts to develop advanced solutions have led to significant investments from both government and private organizations. In June 2023, Royal Philips announced that the Philips-coordinated IMAGIO consortium of clinical partners received a grant of approximately USD 25.97 million. This funding is intended to support research on minimally invasive cancer treatments, with a focus on liver cancer, lung cancer, and soft tissue sarcomas. Such investments are crucial for advancing interventional oncology technologies and improving patient outcomes.

Global Interventional Oncology Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021-2033. The report has segmented the global interventional oncology market report based on technique, procedures, application, end-use, and region:

Techniques Outlook (Revenue, USD Million, 2021-2033)

  • Ablation Therapies
  • Embolization Therapies
  • Biopsy Techniques
  • Targeted Therapy Delivery Systems
  • Image-Guided Procedures

Procedure Outlook (Revenue, USD Million, 2021-2033)

  • Tumor Ablation
  • Tumor Biopsy
  • Vascular Interventions
  • Palliative Care

Application Outlook (Revenue, USD Million, 2021-2033)

  • Liver Cancer
  • Lung Cancer
  • Kidney Cancer
  • Prostate Cancer
  • Breast Cancer
  • Other Cancer

End-use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals
  • Specialty Clinics
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • MEA

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Technique Segment
1.2.2. Procedure Segment
1.2.3. Application Segment
1.2.4. End use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Interventional Oncology Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of cancer
3.2.1.2. Increasing technological advancements in minimally invasive procedures
3.2.1.3. Growing geriatric population
3.2.1.4. Increasing focus on early cancer detection
3.2.1.5. Increasing public and private investments in the field of interventional oncology
3.2.2. Market restraint analysis
3.2.2.1. High cost associated with interventional oncology
3.2.2.2. Requirement of highly skilled professionals
3.3. Interventional Oncology Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Interventional Oncology Market: Technique Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Interventional Oncology Market Product & Service Movement Analysis
4.3. Global Interventional Oncology Market Size & Trend Analysis, by Product & Service, 2021-2033 (USD Million)
4.4. Ablation Therapies
4.4.1. Ablation Therapies market estimates and forecasts, 2021-2033 (USD Million)
4.4.2. Radiofrequency Ablation (RFA)
4.4.2.1. Radiofrequency Ablation (RFA) market estimates and forecasts, 2021-2033 (USD Million)
4.4.3. Microwave Ablation (MWA)
4.4.3.1. Microwave Ablation (MWA) market estimates and forecasts, 2021-2033 (USD Million)
4.4.4. Cryoablation
4.4.4.1. Cryoablation market estimates and forecasts, 2021-2033 (USD Million)
4.4.5. Laser Ablation
4.4.5.1. Laser Ablation market estimates and forecasts, 2021-2033 (USD Million)
4.4.6. Irreversible Electroporation (IRE)
4.4.6.1. Irreversible Electroporation (IRE) market estimates and forecasts, 2021-2033 (USD Million)
4.5. Embolization Therapies
4.5.1. Embolization Therapies market estimates and forecasts, 2021-2033 (USD Million)
4.5.2. Transarterial Chemoembolization (TACE)
4.5.2.1. Transarterial Chemoembolzation (TACE) market estimates and forecasts, 2021-2033 (USD Million)
4.5.3. Transarterial Radioembolization (TARE)
4.5.3.1. Transarterial Radioembolization (TARE) market estimates and forecasts, 2021-2033 (USD Million)
4.6. Biopsy Techniques
4.6.1. Biopsy Techniques market estimates and forecasts, 2021-2033 (USD Million)
4.6.2. Core Needle Biopsy
4.6.2.1. Core Needle Biopsy market estimates and forecasts, 2021-2033 (USD Million)
4.6.3. Fine Needle Aspiration (FNA)
4.6.3.1. Fine Needle Aspiration (FNA) market estimates and forecasts, 2021-2033 (USD Million)
4.7. Targeted Therapy Delivery Systems
4.7.1. Drug Delivery Systems market estimates and forecasts, 2021-2033 (USD Million)
4.7.2. Drug-Eluting Beads
4.7.2.1. Drug-Eluting Beads market estimates and forecasts, 2021-2033 (USD Million)
4.7.3. Radioembolization
4.7.3.1. Radioembolization market estimates and forecasts, 2021-2033 (USD Million)
4.7.4. Drug-Eluting Stents
4.7.4.1. Drug-Eluting Stents market estimates and forecasts, 2021-2033 (USD Million)
4.7.5. Injectable Hydrogels and Nanoparticles
4.7.5.1. Injectable Hydrogels and Nanoparticles market estimates and forecasts, 2021-2033 (USD Million)
4.7.6. Other Targeted Therapy Systems
4.7.6.1. Other Targeted Therapy Systems market estimates and forecasts, 2021-2033 (USD Million)
4.8. Image-Guided Procedures
4.8.1. Image-Guided Procedures market estimates and forecasts, 2021-2033 (USD Million)
4.8.2. Ultrasound Guidance
4.8.2.1. Ultrasound Guidance market estimates and forecasts, 2021-2033 (USD Million)
4.8.3. CT Scan Guidance
4.8.3.1. CT Scan Guidance market estimates and forecasts, 2021-2033 (USD Million)
4.8.4. MRI Guidance
4.8.4.1. MRI Guidance market estimates and forecasts, 2021-2033 (USD Million)
4.8.5. Fluoroscopy Guidance
4.8.5.1. Fluoroscopy Guidance market estimates and forecasts, 2021-2033 (USD Million)
Chapter 5. Interventional Oncology Market: Procedures Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Interventional Oncology Market Procedures Movement Analysis
5.3. Global Interventional Oncology Market Size & Trend Analysis, by Procedure, 2021-2033 (USD Million)
5.4. Tumor Ablation
5.4.1. Tumor Ablation market estimates and forecasts, 2021-2033 (USD Million)
5.5. Tumor Biopsy
5.5.1. Tumor Biopsy market estimates and forecasts, 2021-2033 (USD Million)
5.6. Vascular Interventions
5.6.1. Vascular Interventions market estimates and forecasts, 2021-2033 (USD Million)
5.7. Palliative Care
5.7.1. Palliative Care market estimates and forecasts, 2021-2033 (USD Million)
Chapter 6. Interventional Oncology Materials Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Interventional Oncology Market Application Movement Analysis
6.3. Global Interventional Oncology Market Size & Trend Analysis, by Application, 2021-2033 (USD Million)
6.4. Liver Cancer
6.4.1. Liver Cancer market estimates and forecasts, 2021-2033 (USD Million)
6.5. Lung Cancer
6.5.1. Lung Cancer market estimates and forecasts, 2021-2033 (USD Million)
6.6. Kidney Cancer
6.6.1. Kidney Cancer market estimates and forecasts, 2021-2033 (USD Million)
6.7. Prostate Cancer
6.7.1. Prostate Cancer market estimates and forecasts, 2021-2033 (USD Million)
6.8. Breast Cancer
6.8.1. Breast Cancer market estimates and forecasts, 2021-2033 (USD Million)
6.9. Other Cancer
6.9.1. Other Cancer market estimates and forecasts, 2021-2033 (USD Million)
Chapter 7. Interventional Oncology Market: End use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Interventional Oncology Market End Use Movement Analysis
7.3. Global Interventional Oncology Market Size & Trend Analysis, by End Use, 2021-2033 (USD Million)
7.4. Hospitals
7.4.1. Hospitals market estimates and forecasts, 2021-2033 (USD Million)
7.5. Specialty Clinics
7.5.1. Specialty Clinics market estimates and forecasts, 2021-2033 (USD Million)
7.6. Others
7.6.1. Others market estimates and forecasts, 2021-2033 (USD Million)
Chapter 8. Interventional Oncology Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2021-2033:
8.4. North America
8.4.1. U.S
8.4.1.1. Key country dynamics
8.4.1.2. Competitive scenario
8.4.1.3. Regulatory framework
8.4.1.4. Reimbursement scenario
8.4.1.5. U.S. market estimates and forecasts 2021-2033 (USD Million)
8.4.2. Canada
8.4.2.1. Key country dynamics
8.4.2.2. Competitive scenario
8.4.2.3. Regulatory framework
8.4.2.4. Reimbursement scenario
8.4.2.5. Canada market estimates and forecasts 2021-2033 (USD Million)
8.4.3. Mexico
8.4.3.1. Key country dynamics
8.4.3.2. Competitive scenario
8.4.3.3. Regulatory framework
8.4.3.4. Reimbursement scenario
8.4.3.5. Mexico market estimates and forecasts 2021-2033 (USD Million)
8.5. Europe
8.5.1. UK
8.5.1.1. Key country dynamics
8.5.1.2. Competitive scenario
8.5.1.3. Regulatory framework
8.5.1.4. Reimbursement scenario
8.5.1.5. UK market estimates and forecasts 2021-2033 (USD Million)
8.5.2. Germany
8.5.2.1. Key country dynamics
8.5.2.2. Competitive scenario
8.5.2.3. Regulatory framework
8.5.2.4. Reimbursement scenario
8.5.2.5. Germany market estimates and forecasts 2021-2033 (USD Million)
8.5.3. France
8.5.3.1. Key country dynamics
8.5.3.2. Competitive scenario
8.5.3.3. Regulatory framework
8.5.3.4. Reimbursement scenario
8.5.3.5. France market estimates and forecasts 2021-2033 (USD Million)
8.5.4. Italy
8.5.4.1. Key country dynamics
8.5.4.2. Competitive scenario
8.5.4.3. Regulatory framework
8.5.4.4. Reimbursement scenario
8.5.4.5. Italy market estimates and forecasts 2021-2033 (USD Million)
8.5.5. Spain
8.5.5.1. Key country dynamics
8.5.5.2. Competitive scenario
8.5.5.3. Regulatory framework
8.5.5.4. Reimbursement scenario
8.5.5.5. Spain market estimates and forecasts 2021-2033 (USD Million)
8.5.6. Norway
8.5.6.1. Key country dynamics
8.5.6.2. Competitive scenario
8.5.6.3. Regulatory framework
8.5.6.4. Reimbursement scenario
8.5.6.5. Norway market estimates and forecasts 2021-2033 (USD Million)
8.5.7. Sweden
8.5.7.1. Key country dynamics
8.5.7.2. Competitive scenario
8.5.7.3. Regulatory framework
8.5.7.4. Reimbursement scenario
8.5.7.5. Sweden market estimates and forecasts 2021-2033 (USD Million)
8.5.8. Denmark
8.5.8.1. Key country dynamics
8.5.8.2. Competitive scenario
8.5.8.3. Regulatory framework
8.5.8.4. Reimbursement scenario
8.5.8.5. Denmark market estimates and forecasts 2021-2033 (USD Million)
8.6. Asia-Pacific
8.6.1. Japan
8.6.1.1. Key country dynamics
8.6.1.2. Competitive scenario
8.6.1.3. Regulatory framework
8.6.1.4. Reimbursement scenario
8.6.1.5. Japan market estimates and forecasts 2021-2033 (USD Million)
8.6.2. China
8.6.2.1. Key country dynamics
8.6.2.2. Competitive scenario
8.6.2.3. Regulatory framework
8.6.2.4. Reimbursement scenario
8.6.2.5. China market estimates and forecasts 2021-2033 (USD Million)
8.6.3. India
8.6.3.1. Key country dynamics
8.6.3.2. Competitive scenario
8.6.3.3. Regulatory framework
8.6.3.4. Reimbursement scenario
8.6.3.5. India market estimates and forecasts 2021-2033 (USD Million)
8.6.4. Australia
8.6.4.1. Key country dynamics
8.6.4.2. Competitive scenario
8.6.4.3. Regulatory framework
8.6.4.4. Reimbursement scenario
8.6.4.5. Australia market estimates and forecasts 2021-2033 (USD Million)
8.6.5. South Korea
8.6.5.1. Key country dynamics
8.6.5.2. Competitive scenario
8.6.5.3. Regulatory framework
8.6.5.4. Reimbursement scenario
8.6.5.5. South Korea market estimates and forecasts 2021-2033 (USD Million)
8.6.6. Thailand
8.6.6.1. Key country dynamics
8.6.6.2. Competitive scenario
8.6.6.3. Reimbursement scenario
8.6.6.4. Regulatory framework
8.6.6.5. Thailand market estimates and forecasts 2021-2033 (USD Million)
8.7. Latin America
8.7.1. Brazil
8.7.1.1. Key country dynamics
8.7.1.2. Competitive scenario
8.7.1.3. Regulatory framework
8.7.1.4. Reimbursement scenario
8.7.1.5. Brazil market estimates and forecasts 2021-2033 (USD Million)
8.7.2. Argentina
8.7.2.1. Key country dynamics
8.7.2.2. Competitive scenario
8.7.2.3. Regulatory framework
8.7.2.4. Reimbursement scenario
8.7.2.5. Argentina market estimates and forecasts 2021-2033 (USD Million)
8.8. MEA
8.8.1. South Africa
8.8.1.1. Key country dynamics
8.8.1.2. Competitive scenario
8.8.1.3. Regulatory framework
8.8.1.4. Reimbursement scenario
8.8.1.5. South Africa market estimates and forecasts 2021-2033 (USD Million)
8.8.2. Saudi Arabia
8.8.2.1. Key country dynamics
8.8.2.2. Competitive scenario
8.8.2.3. Regulatory framework
8.8.2.4. Reimbursement scenario
8.8.2.5. Saudi Arabia market estimates and forecasts 2021-2033 (USD Million)
8.8.3. UAE
8.8.3.1. Key country dynamics
8.8.3.2. Competitive scenario
8.8.3.3. Regulatory framework
8.8.3.4. Reimbursement scenario
8.8.3.5. UAE market estimates and forecasts 2021-2033 (USD Million)
8.8.4. Kuwait
8.8.4.1. Key country dynamics
8.8.4.2. Competitive scenario
8.8.4.3. Regulatory framework
8.8.4.4. Reimbursement scenario
8.8.4.5. Kuwait market estimates and forecasts 2021-2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2023
9.4. Company Profiles/Listing
9.4.1. Medtronic plc
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Boston Scientific Corporation
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Johnson & Johnson (Ethicon)
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Baxter International Inc
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Cook Medical
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. C.R. Bard Inc. (Acquired by BD)
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. AngioDynamics Inc
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Stryker Corporation
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. B. Braun Melsungen AG
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Terumo Corporation
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
9.4.11. Siemens Healthineers
9.4.11.1. Company overview
9.4.11.2. Financial performance
9.4.11.3. Product benchmarking
9.4.11.4. Strategic initiatives
9.4.12. GE Healthcare
9.4.12.1. Company overview
9.4.12.2. Financial performance
9.4.12.3. Product benchmarking
9.4.12.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Global interventional oncology market, by region, 2021-2033 (USD Million)
Table 3 Global interventional oncology market, by technique, 2021-2033 (USD Million)
Table 4 Global interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 5 Global interventional oncology market, by application, 2021-2033 (USD Million)
Table 6 Global interventional oncology market, by End use, 2021-2033 (USD Million)
Table 7 North America interventional oncology market, by country, 2021-2033 (USD Million)
Table 8 North America interventional oncology market, by technique, 2021-2033 (USD Million)
Table 9 North America interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 10 North America interventional oncology market, by application, 2021-2033 (USD Million)
Table 11 North America interventional oncology market, by End use, 2021-2033 (USD Million)
Table 12 U.S. interventional oncology market, by technique, 2021-2033 (USD Million)
Table 13 U.S. interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 14 U.S. interventional oncology market, by application, 2021-2033 (USD Million)
Table 15 U.S. interventional oncology market, by End use, 2021-2033 (USD Million)
Table 16 Canada interventional oncology market, by technique, 2021-2033 (USD Million)
Table 17 Canada interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 18 Canada interventional oncology market, by application, 2021-2033 (USD Million)
Table 19 Canada interventional oncology market, by End use, 2021-2033 (USD Million)
Table 20 Mexico interventional oncology market, by technique, 2021-2033 (USD Million)
Table 21 Mexico interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 22 Mexico interventional oncology market, by application, 2021-2033 (USD Million)
Table 23 Mexico interventional oncology market, by End use, 2021-2033 (USD Million)
Table 24 Europe interventional oncology market, by country, 2021-2033 (USD Million)
Table 25 Europe interventional oncology market, by technique, 2021-2033 (USD Million)
Table 26 Europe interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 27 Europe interventional oncology market, by application, 2021-2033 (USD Million)
Table 28 Europe interventional oncology market, by End use, 2021-2033 (USD Million)
Table 29 Germany interventional oncology market, by technique, 2021-2033 (USD Million)
Table 30 Germany interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 31 Germany interventional oncology market, by application, 2021-2033 (USD Million)
Table 32 Germany interventional oncology market, by End use, 2021-2033 (USD Million)
Table 33 UK interventional oncology market, by technique, 2021-2033 (USD Million)
Table 34 UK interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 35 UK interventional oncology market, by application, 2021-2033 (USD Million)
Table 36 UK interventional oncology market, by End use, 2021-2033 (USD Million)
Table 37 France interventional oncology market, by technique, 2021-2033 (USD Million)
Table 38 France interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 39 France interventional oncology market, by application, 2021-2033 (USD Million)
Table 40 France interventional oncology market, by End use, 2021-2033 (USD Million)
Table 41 Italy interventional oncology market, by technique, 2021-2033 (USD Million)
Table 42 Italy interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 43 Italy interventional oncology market, by application, 2021-2033 (USD Million)
Table 44 Italy interventional oncology market, by End use, 2021-2033 (USD Million)
Table 45 Spain interventional oncology market, by technique, 2021-2033 (USD Million)
Table 46 Spain interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 47 Spain interventional oncology market, by application, 2021-2033 (USD Million)
Table 48 Spain interventional oncology market, by End use, 2021-2033 (USD Million)
Table 49 Denmark interventional oncology market, by technique, 2021-2033 (USD Million)
Table 50 Denmark interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 51 Denmark interventional oncology market, by application, 2021-2033 (USD Million)
Table 52 Denmark interventional oncology market, by End use, 2021-2033 (USD Million)
Table 53 Sweden interventional oncology market, by technique, 2021-2033 (USD Million)
Table 54 Sweden interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 55 Sweden interventional oncology market, by application, 2021-2033 (USD Million)
Table 56 Sweden interventional oncology market, by End use, 2021-2033 (USD Million)
Table 57 Norway interventional oncology market, by technique, 2021-2033 (USD Million)
Table 58 Norway interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 59 Norway interventional oncology market, by application, 2021-2033 (USD Million)
Table 60 Norway interventional oncology market, by End use, 2021-2033 (USD Million)
Table 61 Asia-Pacific interventional oncology market, by country, 2021-2033 (USD Million)
Table 62 Asia-Pacific interventional oncology market, by technique, 2021-2033 (USD Million)
Table 63 Asia-Pacific interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 64 Asia-Pacific interventional oncology market, by application, 2021-2033 (USD Million)
Table 65 Asia-Pacific interventional oncology market, by End use, 2021-2033 (USD Million)
Table 66 China interventional oncology market, by technique, 2021-2033 (USD Million)
Table 67 China interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 68 China interventional oncology market, by application, 2021-2033 (USD Million)
Table 69 China interventional oncology market, by End use, 2021-2033 (USD Million)
Table 70 Japan interventional oncology market, by technique, 2021-2033 (USD Million)
Table 71 Japan interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 72 Japan interventional oncology market, by application, 2021-2033 (USD Million)
Table 73 Japan interventional oncology market, by End use, 2021-2033 (USD Million)
Table 74 India interventional oncology market, by technique, 2021-2033 (USD Million)
Table 75 India interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 76 India interventional oncology market, by application, 2021-2033 (USD Million)
Table 77 India interventional oncology market, by End use, 2021-2033 (USD Million)
Table 78 South Korea interventional oncology market, by technique, 2021-2033 (USD Million)
Table 79 South Korea interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 80 South Korea interventional oncology market, by application, 2021-2033 (USD Million)
Table 81 South Korea interventional oncology market, by End use, 2021-2033 (USD Million)
Table 82 Australia interventional oncology market, by technique, 2021-2033 (USD Million)
Table 83 Australia interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 84 Australia interventional oncology market, by application, 2021-2033 (USD Million)
Table 85 Australia interventional oncology market, by End use, 2021-2033 (USD Million)
Table 86 Thailand interventional oncology market, by technique, 2021-2033 (USD Million)
Table 87 Thailand interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 88 Thailand interventional oncology market, by application, 2021-2033 (USD Million)
Table 89 Thailand interventional oncology market, by End use, 2021-2033 (USD Million)
Table 90 Latin America interventional oncology market, by country, 2021-2033 (USD Million)
Table 91 Latin America interventional oncology market, by technique, 2021-2033 (USD Million)
Table 92 Latin America interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 93 Latin America interventional oncology market, by application, 2021-2033 (USD Million)
Table 94 Latin America interventional oncology market, by End use, 2021-2033 (USD Million)
Table 95 Brazil interventional oncology market, by technique, 2021-2033 (USD Million)
Table 96 Brazil interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 97 Brazil interventional oncology market, by application, 2021-2033 (USD Million)
Table 98 Brazil interventional oncology market, by End use, 2021-2033 (USD Million)
Table 99 Argentina interventional oncology market, by technique, 2021-2033 (USD Million)
Table 100 Argentina interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 101 Argentina interventional oncology market, by application, 2021-2033 (USD Million)
Table 102 Argentina interventional oncology market, by End use, 2021-2033 (USD Million)
Table 103 MEA interventional oncology market, by country, 2021-2033 (USD Million)
Table 104 MEA interventional oncology market, by technique, 2021-2033 (USD Million)
Table 105 MEA interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 106 MEA interventional oncology market, by application, 2021-2033 (USD Million)
Table 107 MEA interventional oncology market, by End use, 2021-2033 (USD Million)
Table 108 South Africa interventional oncology market, by technique, 2021-2033 (USD Million)
Table 109 South Africa interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 110 South Africa interventional oncology market, by application, 2021-2033 (USD Million)
Table 111 South Africa interventional oncology market, by End use, 2021-2033 (USD Million)
Table 112 Saudi Arabia interventional oncology market, by technique, 2021-2033 (USD Million)
Table 113 Saudi Arabia interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 114 Saudi Arabia interventional oncology market, by application, 2021-2033 (USD Million)
Table 115 Saudi Arabia interventional oncology market, by End use, 2021-2033 (USD Million)
Table 116 UAE interventional oncology market, by technique, 2021-2033 (USD Million)
Table 117 UAE interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 118 UAE interventional oncology market, by application, 2021-2033 (USD Million)
Table 119 UAE interventional oncology market, by End use, 2021-2033 (USD Million)
Table 120 Kuwait interventional oncology market, by technique, 2021-2033 (USD Million)
Table 121 Kuwait interventional oncology market, by procedure, 2021-2033 (USD Million)
Table 122 Kuwait interventional oncology market, by application, 2021-2033 (USD Million)
Table 123 Kuwait interventional oncology market, by End use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Market formulation & validation
Figure 4 Interventional Oncology market: Market outlook
Figure 5 Interventional Oncology market: Segment outlook
Figure 6 Interventional Oncology market: Competitive landscape outlook
Figure 7 Parent market outlook
Figure 8 Interventional Oncology market driver impact
Figure 9 Interventional Oncology market restraint impact
Figure 10 Interventional Oncology market: Technique outlook and key takeaways
Figure 11 Interventional Oncology market: Technique movement analysis
Figure 12 Ablation Therapies market estimates and forecasts, 2021-2033 (USD Million)
Figure 13 Radiofrequency Ablation (RFA) market estimates and forecasts, 2021-2033 (USD Million)
Figure 14 Microwave Ablation (MWA) market estimates and forecasts, 2021-2033 (USD Million)
Figure 15 Cryoablation market estimates and forecasts, 2021-2033 (USD Million)
Figure 16 Laser Ablation market estimates and forecasts, 2021-2033 (USD Million)
Figure 17 Irreversible Electroporation (IRE) market estimates and forecasts, 2021-2033 (USD Million)
Figure 18 Embolization Therapies market estimates and forecasts, 2021-2033 (USD Million)
Figure 19 Transarterial Chemoembolization (TACE) market estimates and forecasts, 2021-2033 (USD Million)
Figure 20 Transarterial Radioembolization (TARE) market estimates and forecasts, 2021-2033 (USD Million)
Figure 21 Biopsy Techniques market estimates and forecasts, 2021-2033 (USD Million)
Figure 22 Core Needle Biopsy market estimates and forecasts, 2021-2033 (USD Million)
Figure 23 Fine Needle Aspiration (FNA) market estimates and forecasts, 2021-2033 (USD Million)
Figure 24 Targeted Therapy Delivery Systems market estimates and forecasts, 2021-2033 (USD Million)
Figure 25 Drug-Eluting Beads market estimates and forecasts, 2021-2033 (USD Million)
Figure 26 Radioembolization market estimates and forecasts, 2021-2033 (USD Million)
Figure 27 Drug-Eluting Stents market estimates and forecasts, 2021-2033 (USD Million)
Figure 28 Injectable Hydrogels and Nanoparticles market estimates and forecasts, 2021-2033 (USD Million)
Figure 29 Other Targeted Therapy Systems market estimates and forecasts, 2021-2033 (USD Million)
Figure 30 Image-Guided Procedures market estimates and forecasts, 2021-2033 (USD Million)
Figure 31 Ultrasound Guidance market estimates and forecasts, 2021-2033 (USD Million)
Figure 32 CT Scan Guidance market estimates and forecasts, 2021-2033 (USD Million)
Figure 33 MRI Guidance market estimates and forecasts, 2021-2033 (USD Million)
Figure 34 Fluoroscopy Guidance market estimates and forecasts, 2021-2033 (USD Million)
Figure 35 Interventional Oncology market: Procedure outlook and key takeaways
Figure 36 Interventional Oncology market: Procedure movement analysis
Figure 37 Tumor Ablation market estimates and forecasts, 2021-2033 (USD Million)
Figure 38 Tumor Biopsy market estimates and forecasts, 2021-2033 (USD Million)
Figure 39 Vascular Interventions market estimates and forecasts, 2021-2033 (USD Million)
Figure 40 Palliative Care market estimates and forecasts, 2021-2033 (USD Million)
Figure 41 Interventional Oncology market: Application outlook and key takeaways
Figure 42 Interventional Oncology market: Application movement analysis
Figure 43 Liver Cancer market estimates and forecasts, 2021-2033 (USD Million)
Figure 44 Lung Cancer market estimates and forecasts, 2021-2033 (USD Million)
Figure 45 Kidney Cancer market estimates and forecasts, 2021-2033 (USD Million)
Figure 46 Prostate Cancer market estimates and forecasts, 2021-2033 (USD Million)
Figure 47 Breast Cancer market estimates and forecasts, 2021-2033 (USD Million)
Figure 48 Other Cancer market estimates and forecasts, 2021-2033 (USD Million)
Figure 49 Interventional Oncology market: End use outlook and key takeaways
Figure 50 Interventional Oncology market: End use movement analysis market estimates and forecasts, 2021-2033 (USD Million)
Figure 51 Hospitals market estimates and forecasts, 2021-2033 (USD Million)
Figure 52 Specialty Clinics market estimates and forecasts, 2021-2033 (USD Million)
Figure 53 Others market estimates and forecasts, 2021-2033 (USD Million)
Figure 54 Other market estimates and forecasts, 2021-2033 (USD Million)
Figure 55 Global Interventional Oncology market: Regional outlook and key takeaways
Figure 56 Global Interventional Oncology market: Regional movement analysis
Figure 57 North America market estimates and forecasts, 2021-2033 (USD Million)
Figure 58 Key country dynamics
Figure 59 U.S. market estimates and forecasts, 2021-2033 (USD Million)
Figure 60 Target Disease Prevalence
Figure 61 Key country dynamics
Figure 62 Canada market estimates and forecasts, 2021-2033 (USD Million)
Figure 63 Key country dynamics
Figure 64 Mexico market estimates and forecasts, 2021-2033 (USD Million)
Figure 65 Europe market estimates and forecasts, 2021-2033 (USD Million)
Figure 66 Key country dynamics
Figure 67 UK market estimates and forecasts, 2021-2033 (USD Million)
Figure 68 Key country dynamics
Figure 69 Germany market estimates and forecasts, 2021-2033 (USD Million)
Figure 70 Key country dynamics
Figure 71 France market estimates and forecasts, 2021-2033 (USD Million)
Figure 72 Key country dynamics
Figure 73 Italy market estimates and forecasts, 2021-2033 (USD Million)
Figure 74 Key country dynamics
Figure 75 Spain market estimates and forecasts, 2021-2033 (USD Million)
Figure 76 Key country dynamics
Figure 77 Denmark market estimates and forecasts, 2021-2033 (USD Million)
Figure 78 Key country dynamics
Figure 79 Sweden market estimates and forecasts, 2021-2033 (USD Million)
Figure 80 Key country dynamics
Figure 81 Norway market estimates and forecasts, 2021-2033 (USD Million)
Figure 82 Asia-Pacific market estimates and forecasts, 2021-2033 (USD Million)
Figure 83 Key country dynamics
Figure 84 China market estimates and forecasts, 2021-2033 (USD Million)
Figure 85 Key country dynamics
Figure 86 Japan market estimates and forecasts, 2021-2033 (USD Million)
Figure 87 Key country dynamics
Figure 88 India market estimates and forecasts, 2021-2033 (USD Million)
Figure 89 Key country dynamics
Figure 90 Thailand market estimates and forecasts, 2021-2033 (USD Million)
Figure 91 Key country dynamics
Figure 92 South Korea market estimates and forecasts, 2021-2033 (USD Million)
Figure 93 Key country dynamics
Figure 94 Australia market estimates and forecasts, 2021-2033 (USD Million)
Figure 95 Latin America market estimates and forecasts, 2021-2033 (USD Million)
Figure 96 Key country dynamics
Figure 97 Brazil market estimates and forecasts, 2021-2033 (USD Million)
Figure 98 Key country dynamics
Figure 99 Argentina market estimates and forecasts, 2021-2033 (USD Million)
Figure 100 Middle East and Africa market estimates and forecasts, 2021-2033 (USD Million)
Figure 101 Key country dynamics
Figure 102 South Africa market estimates and forecasts, 2021-2033 (USD Million)
Figure 103 Key country dynamics
Figure 104 Saudi Arabia market estimates and forecasts, 2021-2033 (USD Million)
Figure 105 Key country dynamics
Figure 106 UAE market estimates and forecasts, 2021-2033 (USD Million)
Figure 107 Key country dynamics
Figure 108 Kuwait market estimates and forecasts, 2021-2033 (USD Million)

Companies Mentioned

The companies profiled in this Interventional Oncology market report include:
  • Medtronic plc
  • Boston Scientific Corporation
  • Johnson & Johnson (Ethicon)
  • Teleflex Incorporated
  • Cook Medical
  • AngioDynamics Inc.
  • Stryker Corporation
  • Profound Medical
  • Terumo Corporation
  • Siemens Healthineers

Table Information

Report AttributeDetails
No. of Pages210
PublishedDecember 2025
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 2.9 Billion
Forecasted Market Value ( USD ) by 2033 $ 5.61 Billion
Compound Annual Growth Rate8.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Interventional Oncology Devices - Global Strategic Business Report - Product Image

Interventional Oncology Devices - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Interventional Oncology Market by Devices & Consumables (RF, Microwave, Cryoablation. Embolization), Procedures (Thermal Ablation, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung), End User (Hospital, Specialty Clinic) - Global Forecast to 2029 - Product Image

Interventional Oncology Market by Devices & Consumables (RF, Microwave, Cryoablation. Embolization), Procedures (Thermal Ablation, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung), End User (Hospital, Specialty Clinic) - Global Forecast to 2029

  • Report
  • 456 Pages
  • Global
From
Interventional Oncology Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Interventional Oncology Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 110 Pages
  • Global
From
Interventional Oncology Ablation Market - Global Strategic Business Report - Product Image

Interventional Oncology Ablation Market - Global Strategic Business Report

  • Report
  • 373 Pages
  • Global
From
Interventional Oncology Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Interventional Oncology Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 124 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.